William B. Coley Award

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

The William B. Coley Award for Distinguished Research in Basic and Tumor Immunology is presented annually by the Cancer Research Institute, to scientists[1] who have made outstanding achievements in the fields of basic and tumor immunology and whose work has deepened our understanding of the immune system's response to disease, including cancer.

The first awards were made in 1975 to a group of 16 scientists called the "Founders of Cancer Immunology." In 1993, the award was renamed after William B. Coley,[2] a late-nineteenth century surgeon who made the first attempts at the non-surgical treatment of cancer through stimulation of the immune system. For this reason, Coley has become known as the "Father of Cancer Immunotherapy."

Recipients[edit]

Source:[3]

  • 2005: For Distinguished Research in Basic and Tumor Immunology
    000 – James P. Allison

  • 2008: For Distinguished Research in Basic and Tumor Immunology
    000 – Michael John Bevan, FRS

</ref>

  • 2017: Thomas F. Gajewski, for Distinguished Research in Tumor Immunology
    000 – Rafi Ahmed, for Distinguished Research in Basic Immunology

References[edit]

  1. ^ William B. Coley Award Retrieved February 7, 2019.
  2. ^ "CRI History". Retrieved February 7, 2019.
  3. ^ Cancer Research Institute
  4. ^ "Cancer Research Institute to Honor Three Scientists for Outstanding Contributions to Cancer Immunotherapy Research". Cancer Research Institute. July 26, 2016. Retrieved February 7, 2019.
  5. ^ "Three Scientists to Receive Top Honors from the Cancer Research Institute for Outstanding Contributions to Cancer Immunology and Immunotherapy". Cancer Research Institute. September 10, 2018. Retrieved February 7, 2019.